Close
Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Home
Menu
JOIN
SI Premium
Ratings
Mergers
Earnings
Dividends
IPOs
Hedge Funds
Premium Letters
Send a Tip
API/Data
JOIN
SI Premium
Full Feed View
Headline View
SI Premium Squawk Box
Alerts
Custom Headlines
Upgrade Your Current Account
API
Calendars
Co. NDR/Event Calendar
Dividend Calendar
Earnings Calendar
Event Driven
FDA Calendar
Investor Conferences
IPO Calendar
Merger Arb
Ratings Calendar
Stock Split Calendar
Ratings
Analyst Comments
Hot Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades
New Coverage News
Hot New Coverage
Upgrade News
Hot Upgrades
More...
Mergers
Merger News
Hot M&A News
Private Equity
Rumors
SPAC News
Spinoffs
Merger Arbitrage
Event Driven
2021 Top M&A Deals
Top 50 Takeover Targets
More...
Earnings
Earnings Calendar
Earnings News
Hot Earnings
Guidance
Hot Guidance
Conference Calls
Earnings History Search
More...
Dividends
Dividend Calendar
Dividend News
Hot Dividends
Dividend Hike
Special Dividends
Stock Buybacks
Hot Stock Buybacks
Stock Splits
More...
IPOs
IPO News
Hot IPOs
Equity Offerings
Recent IPOs
Upcoming IPOs
2021 Top IPOs
More...
Hedge Funds
13D
13F
13G
Hedge Funds News
Hot Insider Trades
Insider Trades
More...
Premium Letters
Pulse Picks
Stealth Growth Insider
Send a Tip
API/Data
QUICK LINKS :
Goldman Sachs Conviction Buy List
Warren Buffett News
Elliott Management News
Follow @Street_Insider
Adaptimmune Therapeutics (ADAP) Commences MAGE-A10 SPEAR Phase I T-Cell Therapy Triple Tumor Study
Article
Related Press Releases (
1
)
Stock Quotes (1)
FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
StreetInsider.com Top Tickers, 4/17/2024
1.
JBHT
2.
UAL
3.
SAGE
4.
TSLA
5.
TRV
6.
PLD
7.
IBKR
8.
ITCI
9.
SLG
10.
BAC
Top News
Most Read
Special Reports
Stocks decline as interest rate uncertainty, earnings weigh
ASML slides as Q1 sales fall short but firm still on track for 2025 revenue target
US dollar weakens as market consolidates gains, but uptrend intact
Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
Stocks have priced in much of the 2024 optimism - Wells Fargo
Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
Alaska Airlines flights resume after being grounded over aircraft system issue
GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
Barnes & Noble Education (BNED) Enters Definitive Agreement with Immersion (IMMR)
After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
Midday movers: Travelers, JB Hunt fall; United Airlines rises
After-hours movers: United Airlines, J.B. Hunt, and more
Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
Go back to Adaptimmune Therapeutics (ADAP) Commences MAGE-A10 SPEAR Phase I T-Cell Therapy Triple Tumor Study
